search
Open main menu
menu
Close main menu
close
Channels
Longevity/mortality
Accounting/tax
Risk
Capital
Regulation
Investment
Software/IT
People
Risk management
Models
Cat risk
Capital management
Models
Reinsurance
Capital markets
Derivatives
Solvency II
RBC Worldwide
Investment risk/strategy
Asset management
Pension risk transfer
UK
Rest of Europe
US/Canada/Bermuda
ROW
Associations
USA Focus
IFRS 17
Asia Pacific
Climate change and sustainability
Cyber risk
Artificial Intelligence
Events
Market Insight
Awards
Tech guide
Solvency II
Sustainability
Main menu
Sign-in
Register
Home
Archive
NHS funding will be major headwind for UK longevity assumptions
07 October 2022
On the positive side, Hymans Robertson expert points to a potential anti-ageing drug